Drug intelligence / Profile preview

Shensui Tongzhi

Development stage: Preclinical
Lead developer: Zhejiang Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Shensui Tongzhi is a Traditional Chinese Medicine (TCM) herbal prescription developed by The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine. It is specifically formulated for the treatment of early and mid-stage knee osteoarthritis (KOA). The formula is administered orally and is currently being evaluated in a prospective cohort real-world study to assess its clinical efficacy and safety profile. As a TCM intervention, it likely targets systemic and local factors associated with joint degeneration, such as inflammation and cartilage degradation, though its precise molecular mechanisms remain to be fully elucidated in clinical literature.

Other names: Shensui Tongzhi PrescriptionShensui Tongzhi FormulaShensui Tongzhi Fang

Beyond the preview

Go deeper on Shensui Tongzhi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shensui Tongzhi.

Explore the full profile